122111-01-7

122111-01-7

Molecular formula: C19H14F2O6
Molecular weight: 376.31
122111-01-7 is for intermediate for Gemcitabine Hydrochloride.

Send Inquiry

Product Description

2-DEOXY-2,2-DIFLUORO-D-ERYTHRO-PENTOFURANOS-1-ULOSE-3,5-DIBENZOATE

3,3-DIFLUORO-4-BZO-5-BZOMETHYL-DIHYDRO-FURAN-2-ONE

D-ERYTHRO-PENTONIC ACID, 2-DEOXY-2,2-DIFLUORO-GAMMA-LACTONE,3,5-DIBENZOATE

2-Deoxy-2,2-difluoro-D-erythro pentonic acid gamma-lactone 3,5-dibenzoate

2-Deoxy-2,2-difluoro-D-erythro-pentonic acid gamma-lactone 3,5-dibenzoate

2-Deoxy-2,2-difluoro-D-erythropentofuranose-3,5-dibenzoate

D-ERYTHRO-PENTONICACID, 2-DEOXY-2,2-DIFLUORO--LACTONE,3,5-DIBENZOATE

(D-Erythro,d-thero)-2-Deoxy-2,2-difluoro pentafuranose-1-ulose-3,5-di benzoate

2-Deoxy-2,2-Difluoro-7-Lactone D-Erythro-Pentonic Acid-3,5-Dibenzoate

3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-Ribono-1,4-Lactone

3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-ribofuran-1-ulose

2'-Deoxy-2',2'-difluoro-D-erythro-pentofuranous-1-ulose- 3,5-dibenzoate

2-deoxy-2,2-difluor opentofuranos-1-ulose-3,5-dibenzoate

2-Doexy-2,2-difluoro-D-Erythro-pentofuranous-1-ulose-3,5-dibenzoate

GEMCITABINE INTERMEDIATE

2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate

2-DEOXY-2,2-DIFLUORO-D-ERYTHRO-PENTOFURANOS-1-ULOSE-3,5-DIBENZOAT

2-deoxy-2,2-difluoro-D-erythro- pentofuranos-1-ulose-3,5-dibenzoate(T6)

3, 5-DISBENZOYLOXY-2-DEOXY-2, 2-DIFLUORO-1-OXORIBOSE

2-Deoxy-2,2-Difluoro-D-Ribofuranofuranose-3,5 CDibenzoate


Molecular formula: C19H14F2O6

Molecular weight: 376.31

122111-01-7 is for intermediate for Gemcitabine Hydrochloride.


Structure:




Hot Tags: 122111-01-7, China, Manufacturer, Supplier, Factory, High Quality
Related Category
Send Inquiry
Please feel free to give your inquiry in the form below. We will reply you in 24 hours.

Offers excellent, comprehensive customer service every step of the way. Before you order, make real time inquiries through...

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy